MUC1 and cancer: In particular, these studies indicate that both the VNTR (MUC1-N) and non-VNTR (MUC1-C) regions contribute to immune evasion by cancer cells, which needs to be taken into consideration and addressed during the further development of MUC1-based cancer vaccines (29–31).